• Study on the Safety and Feasibility of Oral Zinc Acetate Dihydrate for Patients with GNAO1-Related Disorders

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on Lisocabtagene Maraleucel for Adults with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Germany Italy Spain Sweden

  • Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria France Germany Greece +6

  • Comparison of oral versus intravenous paracetamol and ibuprofen for pain relief after knee arthroscopy

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium

  • Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Italy Portugal

  • Study on the Safety and Effectiveness of SRP-9003 and Prednisone for Patients with Limb-Girdle Muscular Dystrophy Type 2E/R4

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Germany Italy Spain

  • Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy The Netherlands Spain

  • Study on Olaparib for Patients with Advanced HER2-Negative Breast Cancer and Specific Genetic Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study of Dazostinag and Pembrolizumab for Adults with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Poland

  • Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

    Not recruiting

    3 1
    Denmark France Germany Hungary Italy The Netherlands +3

powered by